1998
DOI: 10.1046/j.1365-2869.1998.00086.x
|View full text |Cite
|
Sign up to set email alerts
|

Sleep apnoea in endocrine diseases

Abstract: The pertinent literature on the prevalence, clinical manifestations and pathogenic mechanisms of sleep apnoea (SA) in endocrine diseases, namely acromegaly, Cushing syndrome, hypothyroidism and diabetes mellitus was reviewed. An increased prevalence is well documented in patients with active and treated acromegaly. While most authors report peripheral obstruction, due to hypertrophy of tongue and pharyngeal tissues, to be the cause of SA in acromegaly, some findings argue for a role of hormone‐induced changes … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
59
0
6

Year Published

2001
2001
2022
2022

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 90 publications
(66 citation statements)
references
References 7 publications
0
59
0
6
Order By: Relevance
“…Interestingly, a number of maternal factors have been reported to increase the likelihood of developing pre-eclampsia [9], including obesity, insulin resistance, hypertension, and elevated plasma homocysteine levels. Several of these factors are also associated with the development of OSAS [15].…”
Section: Discussionmentioning
confidence: 99%
“…Interestingly, a number of maternal factors have been reported to increase the likelihood of developing pre-eclampsia [9], including obesity, insulin resistance, hypertension, and elevated plasma homocysteine levels. Several of these factors are also associated with the development of OSAS [15].…”
Section: Discussionmentioning
confidence: 99%
“…The operative team should be aware of the risks of performing the transsphenoidal adenoma resection in acromegalic patients with sleep apnoea in whom upper airway oedema could potentially further aggravate gas exchange postoperatively [67]. Octreotide treatment may promptly alleviate OSAS, and thus its preoperative administration is recommended [72,[75][76][77]. Preoperative nasal CPAP therapy could also reduce the perioperative risks [77].…”
Section: Acromegalymentioning
confidence: 99%
“…Octreotide treatment may promptly alleviate OSAS, and thus its preoperative administration is recommended [72,[75][76][77]. Preoperative nasal CPAP therapy could also reduce the perioperative risks [77]. Sedatives have to be avoided and monitoring of breathing should be extended beyond the immediate postoperative period.…”
Section: Acromegalymentioning
confidence: 99%
“…Some authors describe a prompt reversal of symptoms, sleep-disordered breathing, and nocturnal hypoxia [12], while little or no improvement in sleep apnea is reported by others [10]. Nocturnal Continuous Positive Airway Pressure (nCPAP) treatment can be necessary initially and in some patients even after remission of clinical signs of hypothyroidism [11].…”
mentioning
confidence: 99%